Showing results (1691-1700 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of Pharmacokinetics through Manipulation of Physicochemical Properties in a Series of HCV InhibitorsScott E Lazerwith, Gina Bahador, Eda Canales, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical UtilityLanqi Jia, Robert D Simpson, Jing Yuan, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aryltriflates as a Neglected Moiety in Medicinal Chemistry: A Case Study from a Lead Optimization of CXCL8 InhibitorsAlessio Moriconi, Chiara Bigogno, Gianluca Bianchini, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating CancerMatthew T Burger, Sabina Pecchi, Allan Wagman, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Cyclopropyl Carboxamides: A New Oral Antimalarial Series Derived from the Tres Cantos Anti-Malarial Set (TCAMS)Lourdes Rueda, Isabel Castellote, Julia Castro-Pichel, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Copper-Free Click for PET: Rapid 1,3-Dipolar Cycloadditions with a Fluorine-18 CyclooctyneRichard D Carpenter, Sven H Hausner, Julie L Sutcliffe
ACS Medicinal Chemistry Letters|June 6, 2014
Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B AntagonistsAli El-Tayeb, Sebastian Michael, Aliaa Abdelrahman, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 AntagonistChu-Biao Xue, Anlai Wang, Qi Han, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated RatsDinesh A Barawkar, Ashwin Meru, Anish Bandyopadhyay, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chiralityPing Liu, Thomas J Lanza, Marc Chioda, et al.
Pageof 438